News | April 16, 2021
Aceto acquires specialty exipients company A&C
Acquisition of A&C expands Aceto’s Western manufacturing footprint
Acquisition of A&C expands Aceto’s Western manufacturing footprint
The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions
This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs
Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.
The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades
PEL will explore the PLI scheme and apply if its beneficial.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
Subscribe To Our Newsletter & Stay Updated
